Legend Biotech Announces Participation in Upcoming Investor Conferences

Author's Avatar
Aug 19, 2022

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced its participation in the upcoming investor conferences: